\(
\def\WIPO{World Intellectual Property Organisation}
\)
European patent opposition outcomes in biotechnology.
2023
Formatos
| Formato | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DataCite | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Cite
Citation
Detalles
Título
European patent opposition outcomes in biotechnology.
Tipo de elemento
Journal article
Descripción
1 volume.
Resúmen
Oppositions to patent grants are a means to attack competitors and protect a firm's own patent portfolio. Extant literature has analyzed the determinants of oppositions, while the drivers of opposition outcomes are less known. We study 290 EPO biotech patent oppositions filed in 2012–2019. There are three possible outcomes of opposition proceedings: patent revocation, patent amendment, and opposition rejection. We find that opponents who know the patent's technology are more likely to obtain a patent revocation, while opponents who compete in the product market with the patent owner are more likely to receive a rejection.
Source of Description
Crossref
Serie
World Patent Information ; 73, June, 2023.
En
World Patent Information
Recursos vinculados
Publicado
Oxford [England] : Elsevier Ltd., 2023
Lengua(s)
eng
Derechos de autor
https://www.sciencedirect.com/science/article/abs/pii/S0172219023000108
El registro aparece en